Stay Up-to-Date with Oncology Webinars

Join Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC (Minnesota Oncology), to explore the clinical potential of tislelizumab in advanced or metastatic ESCC and G/GEJ adenocarcinoma.

This session will review:

Join us for an in-depth exploration of endocrine therapy resistance in HR+, HER2- advanced breast cancer, with a focus on ESR1 mutations and their impact on treatment decisions.

This session will cover essential insights to guide clinical practice:

• Types of endocrine therapy resistance and the role of ESR1 mutations

• Testing guidelines and clinical implementation of ESR1 mutation testing

• Available therapies targeting ESR1 mutations and best practices for patient care

Speakers:
Julia Lea Ziegengeist, PharmD, BCOP | Atrium Health
Heather N. Moore, PharmD, BCOP, CPP | Duke University Hospital

Presentations include:

NCODA Regional Leader Opening Remarks – Region 17 (TX)
Tonya Robinson, RN, BSN, AM-BC | MD Anderson Cancer Center

NCODA Progressing with Passion – Exciting Organization Updates
Katie Edmiston | NCODA

Learn about the latest updates and progress at NCODA as we continue our efforts to drive innovation and enhance patient care.

Pacritinib in Cytopenic Myelofibrosis
Nicole Bentivegna, PharmD, BCOP | Florida Cancer Specialists & Research Institute
Vonda McClendon, CPhT | Texas Oncology Pharmacy Services

Explore strategies for transitioning patients with cytopenic myelofibrosis to pacritinib, including dosing considerations, managing hematologic adverse events through appropriate lab monitoring, and the role of proactive patient education in supporting adherence, minimizing complications, and improving outcomes.

CLL Treatment Trends & Takeaways: A Dive into the Insights Report
Kirollos Hanna, PharmD, BCPS, BCOP, FACCC, FAPO | Minnesota Oncology

Discover a personalized approach to treating newly diagnosed CLL, highlighting the role of BTK inhibitors in high-risk patients, the impact of genetic profiling and patient preferences, and strategies for monitoring, care coordination, and cost-effective decision-making.

Presentations include:

Exploring NCODA’s Treatment Support Kits
Austin Starkey, PharmD | NCODA

Empowering Cancer Survivors & Caregivers with Manta Cares
Samira Daswani | Founder and CEO, Manta Cares

As a cancer survivor, Samira built Manta Cares to support survivors and caregivers with tools and resources that bring control and peace of mind to the cancer journey. She also hosts Patient from Hell, a podcast ranked in the top 10% globally on Spotify, where she shares powerful stories and insights on patient advocacy.

Join us as we discuss her personal experience, the mission of Manta Cares, and the impact of innovative healthcare solutions on the patient experience.